Page last updated: 2024-11-08

decyltetraoxyethylene glycol monoether

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID526715
SCHEMBL ID60975
MeSH IDM0189631

Synonyms (23)

Synonym
tetraethylene glycol, decyl ether
2-(2-(2-(2-decyloxy-ethoxy)-ethoxy)-ethoxy)-ethanol
3,6,9,12-tetraoxadocosan-1-ol
tetraethylene glycol monodecyl ether, ~97% (gc)
decyltetraoxyethylene glycol monoether
2-[2-[2-(2-decoxyethoxy)ethoxy]ethoxy]ethanol
5703-94-6
c10-e-4
decyltetraoxyethylene ether
c10e4
tetraethylene glycol monodecyl ether
tetraethyleneglycol monodecyl ether
SCHEMBL60975
tetraethyleneglycolmonodecyl ether
ASMWIUUCZFNLHL-UHFFFAOYSA-N
DTXSID10205645
mfcd00043359
ce;tetraethyleneglycolmonodecylether;n-decyltetraoxyethylene
c10-alcohol-4-ethoxylate
c10-aeo-4
BCP34663
decyltetraoxyethylene glycol monoether;c10e4 tetraethyleneglycolmonodecylether;3,6,9,12-tetraoxadocosan-1-ol
CS-0453804
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's4 (66.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.84

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.84 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.78 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.84)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]